The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeting HER2/neu antigen to B cells via CD19 molecule: A vaccine approach for breast cancer immunotherapy.
D. Xiang
No relevant relationships to disclose
Y. Ma
No relevant relationships to disclose
C. Ding
No relevant relationships to disclose
G. H. Kloecker
No relevant relationships to disclose
J. Yan
No relevant relationships to disclose